The New England Journal of Medicine, ISSN 0028-4793, 04/2011, Volume 364, Issue 15, pp. 1407 - 1418
In this cluster-randomized trial, the use of expanded barrier precautions did not decrease the incidence of vancomycin-resistant enterococcus and...
MEDICINE, GENERAL & INTERNAL | PREVENTING NOSOCOMIAL TRANSMISSION | IMPACT | UNIT | ACTIVE SURVEILLANCE | ACQUISITION | STAPHYLOCOCCUS-AUREUS MRSA | CHLORHEXIDINE | ENTEROCOCCI | NASAL CARRIAGE | GOWN-USE | Intensive Care Units | Surgical Attire - statistics & numerical data | Cross Infection - prevention & control | Humans | Vancomycin Resistance | Colony Count, Microbial | Infection Control - methods | Disease Transmission, Infectious - prevention & control | Methicillin-Resistant Staphylococcus aureus | Cross Infection - transmission | Staphylococcal Infections - transmission | Anti-Bacterial Agents - therapeutic use | Gloves, Protective - statistics & numerical data | Hand Disinfection | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Patient Isolation | Staphylococcal Infections - prevention & control | Enterococcus - drug effects | Staphylococcal Infections - microbiology | Gram-Positive Bacterial Infections - prevention & control | Medical personnel | Intensive care units | Care and treatment | Usage | Staphylococcus aureus infections | Practice | Management | Health risk assessment | Risk factors | Intervention | Staphylococcus infections | Health Insurance Portability & Accountability Act 1996-US | Mathematical models | Shipments
MEDICINE, GENERAL & INTERNAL | PREVENTING NOSOCOMIAL TRANSMISSION | IMPACT | UNIT | ACTIVE SURVEILLANCE | ACQUISITION | STAPHYLOCOCCUS-AUREUS MRSA | CHLORHEXIDINE | ENTEROCOCCI | NASAL CARRIAGE | GOWN-USE | Intensive Care Units | Surgical Attire - statistics & numerical data | Cross Infection - prevention & control | Humans | Vancomycin Resistance | Colony Count, Microbial | Infection Control - methods | Disease Transmission, Infectious - prevention & control | Methicillin-Resistant Staphylococcus aureus | Cross Infection - transmission | Staphylococcal Infections - transmission | Anti-Bacterial Agents - therapeutic use | Gloves, Protective - statistics & numerical data | Hand Disinfection | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Patient Isolation | Staphylococcal Infections - prevention & control | Enterococcus - drug effects | Staphylococcal Infections - microbiology | Gram-Positive Bacterial Infections - prevention & control | Medical personnel | Intensive care units | Care and treatment | Usage | Staphylococcus aureus infections | Practice | Management | Health risk assessment | Risk factors | Intervention | Staphylococcus infections | Health Insurance Portability & Accountability Act 1996-US | Mathematical models | Shipments
Journal Article
Nature Reviews Microbiology, ISSN 1740-1526, 04/2012, Volume 10, Issue 4, pp. 266 - 278
The genus Enterococcus includes some of the most important nosocomial multidrug-resistant organisms, and these pathogens usually affect patients who are...
URINARY-TRACT-INFECTION | FAECALIS PATHOGENICITY ISLAND | NOSOCOMIAL PATHOGEN | LIPOTEICHOIC ACID | QUINUPRISTIN-DALFOPRISTIN | SURFACE PROTEIN ESP | MICROBIOLOGY | STAPHYLOCOCCUS-AUREUS | COLLAGEN ADHESIN | QUORUM-SENSING SYSTEM | BIOFILM FORMATION | Enterococcus faecium - drug effects | Virulence Factors - genetics | Humans | Bacterial Proteins - genetics | Gastrointestinal Tract - microbiology | Enterococcus faecium - genetics | Gram-Positive Bacterial Infections - epidemiology | Anti-Bacterial Agents - therapeutic use | Vancomycin Resistance - physiology | Animals | Enterococcus faecium - pathogenicity | Cross Infection - microbiology | Enteritis - microbiology | Gram-Positive Bacterial Infections - transmission | Vancomycin - pharmacology | Gram-Positive Bacterial Infections - microbiology | Bacterial Proteins - metabolism | Virulence Factors - metabolism | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Microbial Interactions | Enteritis - epidemiology | Cross Infection - epidemiology | Vancomycin Resistance - genetics | Enterococcal infections | Drug resistance in microorganisms | Complications and side effects | Care and treatment | Development and progression | Research | Vancomycin | Risk factors
URINARY-TRACT-INFECTION | FAECALIS PATHOGENICITY ISLAND | NOSOCOMIAL PATHOGEN | LIPOTEICHOIC ACID | QUINUPRISTIN-DALFOPRISTIN | SURFACE PROTEIN ESP | MICROBIOLOGY | STAPHYLOCOCCUS-AUREUS | COLLAGEN ADHESIN | QUORUM-SENSING SYSTEM | BIOFILM FORMATION | Enterococcus faecium - drug effects | Virulence Factors - genetics | Humans | Bacterial Proteins - genetics | Gastrointestinal Tract - microbiology | Enterococcus faecium - genetics | Gram-Positive Bacterial Infections - epidemiology | Anti-Bacterial Agents - therapeutic use | Vancomycin Resistance - physiology | Animals | Enterococcus faecium - pathogenicity | Cross Infection - microbiology | Enteritis - microbiology | Gram-Positive Bacterial Infections - transmission | Vancomycin - pharmacology | Gram-Positive Bacterial Infections - microbiology | Bacterial Proteins - metabolism | Virulence Factors - metabolism | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Microbial Interactions | Enteritis - epidemiology | Cross Infection - epidemiology | Vancomycin Resistance - genetics | Enterococcal infections | Drug resistance in microorganisms | Complications and side effects | Care and treatment | Development and progression | Research | Vancomycin | Risk factors
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 03/2013, Volume 11, Issue 3, pp. 297 - 308
In recent years, the Infectious Diseases Society of America has highlighted a faction of antibiotic-resistant bacteria (Enterococcus faecium, Staphylococcus...
Klebsiella | multidrug resistance | Enterobacter | ESKAPE pathogens | antimicrobial resistance | MRSA | VRE | Acinetobacter | hospital-acquired infection | Pseudomonas | antibiotics | MULTIDRUG-RESISTANT | ESCHERICHIA-COLI | GENERAL STRESS-RESPONSE | RESISTANT STAPHYLOCOCCUS-AUREUS | NEGATIVE BACTERIAL-INFECTIONS | NOSOCOMIAL PATHOGENS | ACINETOBACTER-BAUMANNII | PANTON-VALENTINE LEUKOCIDIN | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | Gram-Positive Cocci - drug effects | Bacterial Infections - drug therapy | Cross Infection - physiopathology | Humans | Bacterial Infections - transmission | Cross Infection - drug therapy | Bacterial Infections - physiopathology | Cross Infection - transmission | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Gram-Positive Cocci - pathogenicity | Cross Infection - microbiology | Gram-Negative Bacteria - pathogenicity | Gram-Positive Cocci - classification | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Bacterial Infections - microbiology | Gram-Negative Bacteria - classification | Usage | Control | Pathogenic microorganisms | Antibiotics | Research | Drug resistance | Health aspects | Varieties
Klebsiella | multidrug resistance | Enterobacter | ESKAPE pathogens | antimicrobial resistance | MRSA | VRE | Acinetobacter | hospital-acquired infection | Pseudomonas | antibiotics | MULTIDRUG-RESISTANT | ESCHERICHIA-COLI | GENERAL STRESS-RESPONSE | RESISTANT STAPHYLOCOCCUS-AUREUS | NEGATIVE BACTERIAL-INFECTIONS | NOSOCOMIAL PATHOGENS | ACINETOBACTER-BAUMANNII | PANTON-VALENTINE LEUKOCIDIN | PSEUDOMONAS-AERUGINOSA | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | Gram-Positive Cocci - drug effects | Bacterial Infections - drug therapy | Cross Infection - physiopathology | Humans | Bacterial Infections - transmission | Cross Infection - drug therapy | Bacterial Infections - physiopathology | Cross Infection - transmission | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Gram-Positive Cocci - pathogenicity | Cross Infection - microbiology | Gram-Negative Bacteria - pathogenicity | Gram-Positive Cocci - classification | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Bacterial Infections - microbiology | Gram-Negative Bacteria - classification | Usage | Control | Pathogenic microorganisms | Antibiotics | Research | Drug resistance | Health aspects | Varieties
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2010, Volume 38, Issue 5, pp. S25 - S33
Health care-associated infections (HAI) remain a major cause of patient morbidity and mortality. Although the main source of nosocomial pathogens is likely the...
Infectious Disease | Infection Control | Environmental surfaces | disinfectants | Acinetobactor | norovirus | Clostridium difficile | SURVIVAL | INFECTIOUS DISEASES | SURROGATE | BAUMANNII | INACTIVATION | FELINE CALICIVIRUS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ENVIRONMENTAL CONTAMINATION | MOLECULAR EPIDEMIOLOGY | DISINFECTION | OUTBREAK | LONG | Norovirus - isolation & purification | Humans | Vancomycin Resistance | Clostridium Infections - transmission | Clostridium Infections - epidemiology | Clostridium difficile - isolation & purification | Microbial Viability | Acinetobacter Infections - transmission | Gram-Positive Bacterial Infections - epidemiology | Cross Infection - transmission | Caliciviridae Infections - transmission | Hospitals | Environmental Microbiology | Housekeeping, Hospital - methods | Acinetobacter Infections - epidemiology | Enterococcus - isolation & purification | Gram-Positive Bacterial Infections - transmission | Disinfection - methods | Acinetobacter - isolation & purification | Enterococcus - drug effects | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Caliciviridae Infections - epidemiology | Cross Infection - epidemiology | Cross infection | Disease transmission | Pathogenic microorganisms | Nosocomial infections | Health aspects
Infectious Disease | Infection Control | Environmental surfaces | disinfectants | Acinetobactor | norovirus | Clostridium difficile | SURVIVAL | INFECTIOUS DISEASES | SURROGATE | BAUMANNII | INACTIVATION | FELINE CALICIVIRUS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ENVIRONMENTAL CONTAMINATION | MOLECULAR EPIDEMIOLOGY | DISINFECTION | OUTBREAK | LONG | Norovirus - isolation & purification | Humans | Vancomycin Resistance | Clostridium Infections - transmission | Clostridium Infections - epidemiology | Clostridium difficile - isolation & purification | Microbial Viability | Acinetobacter Infections - transmission | Gram-Positive Bacterial Infections - epidemiology | Cross Infection - transmission | Caliciviridae Infections - transmission | Hospitals | Environmental Microbiology | Housekeeping, Hospital - methods | Acinetobacter Infections - epidemiology | Enterococcus - isolation & purification | Gram-Positive Bacterial Infections - transmission | Disinfection - methods | Acinetobacter - isolation & purification | Enterococcus - drug effects | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Caliciviridae Infections - epidemiology | Cross Infection - epidemiology | Cross infection | Disease transmission | Pathogenic microorganisms | Nosocomial infections | Health aspects
Journal Article
Journal of Hospital Infection, ISSN 0195-6701, 2015, Volume 91, Issue 3, pp. 211 - 217
Summary A systematic review and meta-analysis was conducted to determine the risk of pathogen acquisition for patients associated with prior room occupancy....
Infectious Disease | Cleaning | Prior room occupancy | Acquisition | Infection control | SURVIVAL | INFECTIOUS DISEASES | BACTERIA | ENTEROCOCCI | RESISTANT STAPHYLOCOCCUS-AUREUS | CLOSTRIDIUM-DIFFICILE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | VENTILATION | PSEUDOMONAS-AERUGINOSA | ENVIRONMENTAL CONTAMINATION | COLONIZATION PRESSURE | OUTBREAK | Risk Assessment | Cross Infection - prevention & control | Humans | Infection Control - methods | Cross Infection - transmission | Gram-Negative Bacterial Infections - microbiology | Hospitals | Environmental Microbiology | Cross Infection - microbiology | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Gram-Negative Bacterial Infections - prevention & control | Disease Transmission, Infectious | Gram-Negative Bacterial Infections - transmission | Gram-Positive Bacterial Infections - prevention & control | Cleaning services industry
Infectious Disease | Cleaning | Prior room occupancy | Acquisition | Infection control | SURVIVAL | INFECTIOUS DISEASES | BACTERIA | ENTEROCOCCI | RESISTANT STAPHYLOCOCCUS-AUREUS | CLOSTRIDIUM-DIFFICILE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | VENTILATION | PSEUDOMONAS-AERUGINOSA | ENVIRONMENTAL CONTAMINATION | COLONIZATION PRESSURE | OUTBREAK | Risk Assessment | Cross Infection - prevention & control | Humans | Infection Control - methods | Cross Infection - transmission | Gram-Negative Bacterial Infections - microbiology | Hospitals | Environmental Microbiology | Cross Infection - microbiology | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Gram-Negative Bacterial Infections - prevention & control | Disease Transmission, Infectious | Gram-Negative Bacterial Infections - transmission | Gram-Positive Bacterial Infections - prevention & control | Cleaning services industry
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 05/2003, Volume 24, Issue 5, pp. 362 - 386
BACKGROUND: Infection control programs were created three decades ago to control antibiotic-resistant healthcare-associated infections, but there has been...
METHICILLIN-RESISTANT | BACTERIAL-CONTAMINATION | VANCOMYCIN-RESISTANT | INFECTIOUS DISEASES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-FACTORS | INTENSIVE-CARE-UNIT | GENETIC BACKGROUNDS | MOLECULAR EPIDEMIOLOGY | HOSPITAL-ACQUIRED INFECTION | ANTIMICROBIAL RESISTANCE | HAND-HYGIENE REGIMENS | Cross Infection - prevention & control | Humans | Vancomycin Resistance | Equipment Contamination | Infection Control - methods | Cross Infection - transmission | Staphylococcal Infections - transmission | Infection Control - standards | Cross Infection - microbiology | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Staphylococcal Infections - prevention & control | Enterococcus - drug effects | Protective Clothing | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Anti-Bacterial Agents - administration & dosage | Gram-Positive Bacterial Infections - prevention & control
METHICILLIN-RESISTANT | BACTERIAL-CONTAMINATION | VANCOMYCIN-RESISTANT | INFECTIOUS DISEASES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-FACTORS | INTENSIVE-CARE-UNIT | GENETIC BACKGROUNDS | MOLECULAR EPIDEMIOLOGY | HOSPITAL-ACQUIRED INFECTION | ANTIMICROBIAL RESISTANCE | HAND-HYGIENE REGIMENS | Cross Infection - prevention & control | Humans | Vancomycin Resistance | Equipment Contamination | Infection Control - methods | Cross Infection - transmission | Staphylococcal Infections - transmission | Infection Control - standards | Cross Infection - microbiology | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Staphylococcal Infections - prevention & control | Enterococcus - drug effects | Protective Clothing | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Anti-Bacterial Agents - administration & dosage | Gram-Positive Bacterial Infections - prevention & control
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 12/2016, Volume 54, Issue 12, pp. 2874 - 2881
The increasing prevalence of multidrug-resistant (MDR) bacteria is a serious global challenge. Here, we studied prospectively whether bacterial whole-genome...
MICROBIOLOGY | EVOLUTION | OUTBREAK | EMERGENCE | STAPHYLOCOCCUS-AUREUS ST398 | Enterococcus faecium - drug effects | Pseudomonas aeruginosa - isolation & purification | Prospective Studies | Vancomycin-Resistant Enterococci - drug effects | Escherichia coli - drug effects | Humans | Infection Control - methods | Enterococcus faecium - isolation & purification | Cross Infection - transmission | Microbial Sensitivity Tests | Piperacillin - pharmacology | Gram-Positive Bacterial Infections - transmission | Vancomycin-Resistant Enterococci - genetics | Methicillin-Resistant Staphylococcus aureus - genetics | Methicillin-Resistant Staphylococcus aureus - drug effects | Ciprofloxacin - pharmacology | Enterococcus faecium - genetics | Pseudomonas aeruginosa - drug effects | Sequence Analysis, DNA | Pseudomonas Infections - transmission | Staphylococcal Infections - transmission | Genome, Bacterial - genetics | Vancomycin-Resistant Enterococci - isolation & purification | Pseudomonas aeruginosa - genetics | Escherichia coli - genetics | Escherichia coli - isolation & purification | Cross Infection - microbiology | Escherichia coli Infections - transmission | Cefotaxime - pharmacology | Anti-Bacterial Agents - pharmacology | High-Throughput Nucleotide Sequencing | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteriology
MICROBIOLOGY | EVOLUTION | OUTBREAK | EMERGENCE | STAPHYLOCOCCUS-AUREUS ST398 | Enterococcus faecium - drug effects | Pseudomonas aeruginosa - isolation & purification | Prospective Studies | Vancomycin-Resistant Enterococci - drug effects | Escherichia coli - drug effects | Humans | Infection Control - methods | Enterococcus faecium - isolation & purification | Cross Infection - transmission | Microbial Sensitivity Tests | Piperacillin - pharmacology | Gram-Positive Bacterial Infections - transmission | Vancomycin-Resistant Enterococci - genetics | Methicillin-Resistant Staphylococcus aureus - genetics | Methicillin-Resistant Staphylococcus aureus - drug effects | Ciprofloxacin - pharmacology | Enterococcus faecium - genetics | Pseudomonas aeruginosa - drug effects | Sequence Analysis, DNA | Pseudomonas Infections - transmission | Staphylococcal Infections - transmission | Genome, Bacterial - genetics | Vancomycin-Resistant Enterococci - isolation & purification | Pseudomonas aeruginosa - genetics | Escherichia coli - genetics | Escherichia coli - isolation & purification | Cross Infection - microbiology | Escherichia coli Infections - transmission | Cefotaxime - pharmacology | Anti-Bacterial Agents - pharmacology | High-Throughput Nucleotide Sequencing | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteriology
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 07/2012, Volume 18, Issue 7, pp. 619 - 625
Enterococci are commensal bacteria in the intestines of humans and animals, but also cause infections in humans. Most often, isolates from clinical outbreaks...
Enterococcus faecalis | Enterococcus faecium | growth promoters | gene transfer | molecular typing | Molecular typing | Gene transfer | Growth promoters | INFECTIOUS DISEASES | GLYCOPEPTIDE RESISTANCE | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | VANCOMYCIN-RESISTANT ENTEROCOCCI | FAECIUM ISOLATE | ANTIMICROBIAL RESISTANCE | IN-VIVO | GENE-TRANSFER | TYPING SCHEME | HUMAN VOLUNTEERS | DIGESTIVE-TRACT | Enterococcus faecalis - pathogenicity | Enterococcus faecium - drug effects | Public Health | Enterococcus faecalis - drug effects | Humans | Bacterial Proteins - genetics | Drug Resistance, Bacterial | Genotype | Bacterial Infections - transmission | Bacterial Infections - veterinary | Zoonoses - transmission | Animals | Carbon-Oxygen Ligases - genetics | Enterococcus faecium - pathogenicity | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Disease Reservoirs | Bacterial Infections - microbiology | Zoonoses - microbiology | Gram-Positive Bacterial Infections - veterinary | Infection | Horizontal transfer | Commensals | Intestine | Vancomycin | Drug resistance | Public health | Food | Meat | vanA gene
Enterococcus faecalis | Enterococcus faecium | growth promoters | gene transfer | molecular typing | Molecular typing | Gene transfer | Growth promoters | INFECTIOUS DISEASES | GLYCOPEPTIDE RESISTANCE | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | VANCOMYCIN-RESISTANT ENTEROCOCCI | FAECIUM ISOLATE | ANTIMICROBIAL RESISTANCE | IN-VIVO | GENE-TRANSFER | TYPING SCHEME | HUMAN VOLUNTEERS | DIGESTIVE-TRACT | Enterococcus faecalis - pathogenicity | Enterococcus faecium - drug effects | Public Health | Enterococcus faecalis - drug effects | Humans | Bacterial Proteins - genetics | Drug Resistance, Bacterial | Genotype | Bacterial Infections - transmission | Bacterial Infections - veterinary | Zoonoses - transmission | Animals | Carbon-Oxygen Ligases - genetics | Enterococcus faecium - pathogenicity | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Disease Reservoirs | Bacterial Infections - microbiology | Zoonoses - microbiology | Gram-Positive Bacterial Infections - veterinary | Infection | Horizontal transfer | Commensals | Intestine | Vancomycin | Drug resistance | Public health | Food | Meat | vanA gene
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2017, Volume 64, Issue 7, pp. 886 - 893
Background. Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of nosocomial infection. Here, we describe the utility of whole-genome...
Enterococcus faecium | Genome sequencing | Vancomycin resistant | Transmission | Infection control | SPECIES LEVEL | INFECTIOUS DISEASES | RISK-FACTORS | AMPICILLIN-RESISTANT | MICROBIOLOGY | infection control | IMMUNOLOGY | IDENTIFICATION | HOSPITALIZATION | transmission | ASSEMBLIES | STAPHYLOCOCCI | genome sequencing | INTERACTIVE TREE | INFECTION | OUTBREAK | vancomycin resistant | Enterococcus faecium - drug effects | Genome, Bacterial | Vancomycin-Resistant Enterococci | Humans | Cross Infection | Enterococcus faecium - genetics | Phylogeny | Enterococcus faecium - isolation & purification | Whole Genome Sequencing | Enterococcus faecium - classification | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Polymorphism, Single Nucleotide | Retrospective Studies | Enterococcal infections | Care and treatment | Research | Nucleotide sequencing | Epidemiology | DNA sequencing | Major
Enterococcus faecium | Genome sequencing | Vancomycin resistant | Transmission | Infection control | SPECIES LEVEL | INFECTIOUS DISEASES | RISK-FACTORS | AMPICILLIN-RESISTANT | MICROBIOLOGY | infection control | IMMUNOLOGY | IDENTIFICATION | HOSPITALIZATION | transmission | ASSEMBLIES | STAPHYLOCOCCI | genome sequencing | INTERACTIVE TREE | INFECTION | OUTBREAK | vancomycin resistant | Enterococcus faecium - drug effects | Genome, Bacterial | Vancomycin-Resistant Enterococci | Humans | Cross Infection | Enterococcus faecium - genetics | Phylogeny | Enterococcus faecium - isolation & purification | Whole Genome Sequencing | Enterococcus faecium - classification | Gram-Positive Bacterial Infections - transmission | Gram-Positive Bacterial Infections - microbiology | Polymorphism, Single Nucleotide | Retrospective Studies | Enterococcal infections | Care and treatment | Research | Nucleotide sequencing | Epidemiology | DNA sequencing | Major
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2014, Volume 35, Issue 9, pp. 1156 - 1162
Objective. Hand hygiene and environmental cleaning are essential infection prevention strategies, but the relative impact of each is unknown. This information...
Observational research | Original Article | Physicians | Nurses | Health care industry | Mixed strategy | Environmental disorders | Cleaning | Infections | Patient compliance | Modeling | INFECTIOUS DISEASES | HEALTH-CARE WORKERS | BACTERIA | CONTACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ENTEROCOCCUS | ACQUISITION | RISK | CONTAMINATION | STAPHYLOCOCCUS-AUREUS | COLONIZATION | SURFACES | Acinetobacter Infections - prevention & control | Vancomycin-Resistant Enterococci | Cross Infection - prevention & control | Humans | Treatment Outcome | Acinetobacter Infections - transmission | Methicillin-Resistant Staphylococcus aureus | Cross Infection - transmission | Staphylococcal Infections - transmission | Acinetobacter baumannii | Models, Biological | Computer Simulation | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - transmission | Disinfection - methods | Staphylococcal Infections - prevention & control | Gram-Positive Bacterial Infections - prevention & control | Hand Hygiene
Observational research | Original Article | Physicians | Nurses | Health care industry | Mixed strategy | Environmental disorders | Cleaning | Infections | Patient compliance | Modeling | INFECTIOUS DISEASES | HEALTH-CARE WORKERS | BACTERIA | CONTACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ENTEROCOCCUS | ACQUISITION | RISK | CONTAMINATION | STAPHYLOCOCCUS-AUREUS | COLONIZATION | SURFACES | Acinetobacter Infections - prevention & control | Vancomycin-Resistant Enterococci | Cross Infection - prevention & control | Humans | Treatment Outcome | Acinetobacter Infections - transmission | Methicillin-Resistant Staphylococcus aureus | Cross Infection - transmission | Staphylococcal Infections - transmission | Acinetobacter baumannii | Models, Biological | Computer Simulation | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - transmission | Disinfection - methods | Staphylococcal Infections - prevention & control | Gram-Positive Bacterial Infections - prevention & control | Hand Hygiene
Journal Article